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ABSTRACT 
Aim: The overall aim of this thesis is to investigate the long-term course and 
outcome of pediatric OCD following evidence-based treatment of pediatric 
OCD. Outcome is assessed with regard to severity of OCD symptoms (Studies 
I-III), psychosocial functioning (Studies I & II), and depressive symptoms 
(Study II). Method: Studies I and II include the same 109 participants (5-17 
years), assessed and treated in Western Sweden, based on the clinical 
guidelines for OCD and individually adapted for each patient. Study III 
comprises 269 participants (7-17 years) from a multicenter study, in Sweden, 
Norway, and Denmark. Participants were treated with a first step of 
manualized cognitive-behavioral therapy (CBT). Non-responders were 
randomized to an extended treatment of either continued CBT or pharmaco-
therapy with sertraline. Both study samples were repeatedly assessed during a 
three-year follow-up period, using the semi-structured Children’s Yale-Brown 
Obsessive-Compulsive Scale (CY-BOCS) interview, and the self- and parent-
rated questionnaires Children’s OCD Impact Scale (Studies I-II) and 
Children’s Depressive Inventory (Study II). Results: Studies I and II revealed 
a significant improvement of OCD symptoms from baseline to one-year 
follow-up, and improvements maintained and continued until the three-year 
follow-up. Participants’ psychosocial functioning and depressive symptoms 
improved during the follow-up period as well. Further, findings from the Study 
III sample showed that participants’ improvements from the one-year follow-
up were maintained, and symptoms decreased further during the three-year 
follow-up period as well. Improvements were similar regardless of the 
treatment duration and type of extended treatment. Conclusions: The three 
studies indicate that the course of pediatric OCD is favorable, possibly due to 
treatment gains of evidence-based treatment, following expert consensus 
guidelines. Gains were sustained over a three-year period and symptoms 
decreased further during the follow-up period. 
 Keywords: adolescent, child, cognitive behavioral therapy, follow-up, 
obsessive-compulsive disorder, sertraline, symptom assessment, self-
assessment  
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SAMMANFATTNING PÅ SVENSKA 
 
Tvångssyndrom (eng. Obsessive-Compulsive Disorder - OCD) är ett allvarlig 
och förhållandevis vanligt psykiatriskt sjukdomstillstånd som ofta debuterar i 
barn- och ungdomsåren. OCD orsakar ett stort lidande för både 
barnen/ungdomarna och deras familjer. De barn och ungdomar som drabbas, 
hämmas i sin utveckling och får en försämrad psykosocial funktionsförmåga. 
Om barn och ungdomar med OCD inte behandlas kan det hos många bli ett 
kroniskt sjukdomsförlopp och hindra barnets/ungdomens normala utveckling. 
Dessutom finns det risk att utveckla andra psykiska störningar i vuxen ålder. 
Tidigt ställd diagnos och snabb start av behandling kan vara avgörande för att 
förhindra eventuellt livslångt lidande. Kognitiv beteendeterapi (KBT) är 
rekommenderat som förstahandsval av behandling medan 
läkemedelsbehandling med selektiva serotonin återupptags hämmare (SSRI) 
är andrahandsval. Det är väl etablerat att dessa behandlingar har god effekt 
med symtomförbättring på kort sikt, medan långtids förloppet är mindre känt.  
Det övergripande syftet med denna studie är att undersöka långtidsutfallet hos 
barn och ungdomar med OCD, efter att de har behandlats med evidens-
baserade metoder enligt kliniska riktlinjer. Utfallet av behandlingen bedöms 
med avseende på svårighetsgraden av OCD-symtomen (studier I-III), 
psykosocial funktionsförmåga (studier I & II) och depressiva symtom (studie 
II).  
I studierna I och II, ingår samma 109 deltagare (5–17 år, 56% flickor) som är 
bedömda och behandlade i Västsverige, baserat på kliniska riktlinjer för OCD 
och med individuell anpassning för varje enskild patient. Studie III omfattar 
269 deltagare (7–17 år, 51% flickor) från en multicenterstudie, ett samarbete 
mellan forskare och kliniker i Sverige, Norge och Danmark. Deltagarna 
behandlades i första steget med manualbaserad kognitiv beteendeterapi (KBT) 
i 14 veckor. De som inte haft tillräcklig nytta av behandlingen randomiserades 
till en utökad behandling i 16 veckor med antingen fortsatt KBT eller 
medicinering med sertralin. Båda studiegrupperna följdes upp med upprepade 
utvärderingar (fyra tillfällen) under en treårig uppföljningsperiod med hjälp av 
den semi-strukturerade intervjun Children´s Yale-Brown Obsessive 
Compulsive Scale (sv. tvångssymptom skala (CY-BOCS)) och själv-och 
föräldraskattnings frågeformulären Child OCD Impact Scale (Studier I-II) och 
självskattningsskalan Children’s Depressive Inventory (Studie II).  
 Studierna I och II, visade en signifikant förbättring av OCD-symtomen från 
starten av behandling till ett-årsuppföljningen, och att förbättringen bibehölls 
och ökade ytterligare fram till tre-årsuppföljningen. Även deltagarnas 
psykosociala funktion och depressiva symtom förbättrades under 
uppföljningsperioden. Vidare visade resultaten från studie III att deltagarna 
som hade måttlig-svår OCD före behandlingen, hade förbättrats under 
behandlingen och fram till ett-årsuppföljningen. Förbättringen bibehölls under 
uppföljningsperioden och symtomen minskade ytterligare fram till 3-
årsuppföljningen. Resultaten var likvärdiga oavsett behandlingstid och typ av 
utökad behandling. Avhandlingens resultat visar på vikten av att erbjuda KBT 
till unga personer med OCD, då KBT verkar vara den mest fördelaktiga och 
säkra behandlingen, på kort och lång sikt.  
De tre studierna tyder på att långtids förloppet för barn och ungdomar med 
OCD är gynnsam, troligen på grund av evidensbaserad behandling i enlighet 
med de kliniska riktlinjerna. Deltagarna förbättrades under behandlingen och 
symtomen minskade ytterligare under den treåriga uppföljningsperioden. 
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INTRODUCTION 
Obsessive-compulsive disorder (OCD) is a persistent and highly 
disabling psychiatric disorder, which the World Health Organization 
(WHO) ranks as the tenth most disabling medical disorder in the world 
(1). Untreated, pediatric OCD can become chronic and disrupt the 
normal development of a young person, and there is an increased risk of 
developing multiple concurrent mental disorders into adulthood (2, 3). 
Consequently, early diagnosis and treatment is crucial for the prevention 
of possible lifelong impairment (4). Current first-line treatments for 
pediatric OCD are cognitive behavior therapy (CBT) and 
pharmacotherapy with selective serotonin re-uptake inhibitors (SSRI). 
It is well established that these treatments for pediatric OCD are 
associated with significant symptom improvement in the short term, 
based on controlled trials (5-9), although the long-term outcomes are 
less well known. 
Earlier on, many pediatric OCD patients were neither diagnosed nor 
treated adequately. Thus, thirty years ago, the mental health services 
struggled with even recognizing these patients. Moreover, the use of 
evidence-based methods for these patients were erratic at best. Thus, as 
better treatments have become available (5, 9) and been implemented, 
it is important to examine whether the outcome has improved compared 
to earlier studies. 
This thesis will focus on the long-term outcomes of pediatric OCD. 
Two different clinical cohorts, including 109 respectively 269 
children and adolescents with OCD, are followed with assessments 
repeatedly across three years. While the results presented in this thesis 
are limited in several ways, as will be discussed, they can still 
provide important information and increase our knowledge about 
the long-term outcome for pediatric OCD. In particular, these two 
cohorts were provided with evidence-based treatment in accordance 
with clinical guidelines still followed. 
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Characteristics of OCD 
Symptomology 
Pediatric OCD is a heterogeneous condition, in that the specific constellation 
of obsessions and compulsions varies a lot between different persons. Further, 
the OCD symptoms can fluctuate over time, both in intensity and presentation. 
The core features of OCD are obsessions and compulsions, with the former 
characterized as unrealistic, intrusive and unwanted thoughts, urges, or images 
that are recurrent and persistent, and which elicit acts designed to neutralize 
them. Even if the obsessions are unrealistic, they cause marked feelings of 
anxiety, distress, and/or disgust for most of the affected individuals (10, 11). 
The most common obsessions in pediatric OCD are a fear of contamination 
(dirt or germs), fear of harming oneself or important people, or the urge to 
ensure exactness and symmetry (12). Compulsions are repetitive behaviors 
such as excessive washing, checking, ordering, repeating, asking reassurance 
questions, and/or performing mental rituals such as praying, repeating words 
silently, and counting. These compulsions are carried out in order to neutralize 
the anxiety or feeling of distress or disgust caused by the obsessions, as well 
as with the aim of preventing the dangers perceived to be inherent in these 
obsessions (10, 13, 14). The most common compulsions are excessive 
handwashing and a range of other cleaning rituals, as well as checking and 
repeating behaviors (12). 
Furthermore, avoidance behaviors are common and sometimes the most 
frequent and prominent phenomenon present in patients. They occur when a 
person avoids different things, places, people, or situations where obsessions 
might be elicited or evoked. The rationale behind avoidance behaviors is that 
if obsessions can be lessened to the extent that they are no longer present or at 
least less overwhelming, there is no need for compulsive behaviors and anxiety 
is lowered, which in turn strongly reinforces avoidance. Avoidance is 
important as OCD symptoms are maintained by the avoidance behavior and it 
is often an obstacle to working with the symptoms (15-17). In a large (n=317) 
clinical sample of pediatric OCD patients, a high degree of avoidance appears 
to be associated with more severe OCD at baseline and less probability of 
reaching remission (17). 
In OCD with childhood onset, it is common that the children do not talk about 
their symptoms, try to hide them, and keep them secret. The children often feel 
shame and guilt due to their OCD-symptoms. They may also be frightened by 
some of the more bizarre or aggressive obsessions, and dare not talk about 
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them for fear of triggering them. Consequently, for parents and other 
caregivers, the child’s OCD symptoms may not be obvious. However, other 
symptoms may emerge much more clearly, such as irritability, fatigue, 
depressive symptoms, and somatic symptoms. These factors may delay a 
correct diagnosis and appropriate treatment for the child or adolescent.    
Diagnostic criteria 
Diagnostic criteria are presented in the Diagnostic and Statistical Manual of 
Mental Disorders, 5th edition (DSM-5) (10) and in the International 
Classification of Diseases 11th Revision (ICD-11) (18). The diagnostic criteria 
for OCD formulated in the previous edition of the DSM (DSM-IV-TR) (14) 
were used in the present studies, and are presented in Table 1. 
In the DSM-5 (10), OCD is no longer classified as an anxiety disorder, and is 
instead placed in a new chapter called “Obsessive-Compulsive and Related 
Disorders” (OCRD). The new chapter also includes body dysmorphic disorder 
(BDD) and trichotillomania (hair-pulling disorder), as well as two new 
disorders, hoarding disorder and excoriation disorder (skin-picking disorder). 
However, the criteria for OCD in the DSM-5 have not been changed from the 
earlier version, except for a few minor modifications. In the DSM-IV-TR, the 
person’s insight was specified categorically as “poor” or “good”, while in the 
DSM-5 there is a variation in degrees of insight, including good insight, poor 
insight, and absent insight. Hoarding is classified as a separate diagnosis (10), 
though hoarding symptoms fully in consonance with DSM-IV criteria are 
present in pediatric OCD (19).  
The change in classification of OCD in the DSM-5 from an anxiety disorder 
to a placement in the new OCRD chapter has been questioned by Storch et al. 
(20), who argue that such a change in classification lacks expert consensus and 
is insufficiently supported by the extant empirical data. Some of the OCRDs 
are not closely related to one another, for example trichotillomania and 
hoarding disorder.  
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Table 1. Diagnostic criteria for Obsessive-Compulsive Disorder according to DSM-IV-TR. 
 
A. Either obsessions or compulsions:
Obsessions as defined by (1), (2), (3), and (4):
(1) recurrent and persisting thoughts, impulses or images that are experienced, at
some time during the disturbance, as intrusive and inappropriate and that cause
marked anxiety or distress
(2) the thoughts, impulses, or images are not simply excessive worries about real-
life problems
(3) the person attempts to ignore or suppress such thoughts, impulses, or images,
or to neutralize them with some other thought or action
(4) the person recognizes that the obsessional thoughts, impulses, or images are a
product of his or her own mind (not imposed from without as in thought
insertion)
Compulsions as defined by (1) and (2): 
(1) repetitive behaviors (e.g., hand washing, ordering, checking) or mental acts
(e.g., praying, counting, repeating words silently) that the person feels driven
to perform in response to an obsession, or according to rules that must be
applied rigidly
(2) the behaviors or mental acts are aimed at preventing or reducing distress or
preventing some dreaded event or situation; however, these behaviors or
mental acts either are not connected in a realistic way with what they are
designed to neutralize or prevent or are clearly excessive
B. At some point during the course of the disorder, the person has recognized that the
obsessions or compulsions are excessive or unreasonable.
C. The obsessions or compulsions cause marked distress, are time consuming (take more
than 1 hour a day), or significantly interfere with the person's normal routine,
occupational (or academic) functioning, or usual social activities or relationships.
D. If another Axis I disorder is present, the content of the obsessions or compulsions is
not restricted to it (e.g., preoccupation with food in the presence of an Eating
Disorders; hair pulling in the presence of Trichotillomania; concern with appearance
in the presence of Body Dysmorphic Disorder; preoccupation with drugs in the
presence of a Substance Use Disorder; preoccupation with having a serious illness in
the presence of Hypochondriasis; preoccupation with sexual urges or fantasies in the
presence of a Paraphilia; or guilty ruminations in the presence of Major Depressive
Disorder)
E. The disturbance is not due to the direct physiological effects of a substance (e.g., a
drug of abuse, a medication) or a general medical condition
Specify if:  
With Poor Insight: if, for most of the time during the current episode the person does not 
recognize that the obsessions and compulsions are excessive or unreasonable 
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Prevalence and onset  
The prevalence rates of OCD in children and adolescents have been estimated 
as varying between 0.25% and 4% (21-24). The study that estimated a 
prevalence rate as low as 0.25% reported data of a younger population aged 5-
15 years, and indicated that the prevalence rates differ across age groups, with 
the prevalence rising with increasing age. A recent study in Greece estimated 
a prevalence rate of 1.4% in 2427 adolescents aged 16-18 years (25). 
Prevalence rates of childhood OCD are similar to those reported for adults (2-
3%) (26). About 30-50% of adults with OCD developed their illness in 
childhood (27), showing the importance of the outcome of pediatric OCD. 
Population-based studies show a gender ratio close to 1:1 (28).  
The mean age of onset for pediatric OCD is between 10 and 13 years of age 
(22, 28-30). However, participants and parents recalled onset of minor 
symptoms in early childhood (mean=7.0, SD=3.4). Moreover, an earlier age 
of onset of OCD symptoms fulfilling DSM-IV criteria was 9.2 ± 3.6 years, and 
the duration of illness was 4.5 ± 3.0 years in a more recent study (31).  
Functional areas affected by OCD 
Functional impairment 
In pediatric OCD, symptoms usually interfere with the children’s daily 
living, causing severe and enduring impairment of psychosocial functioning 
regard to social, academic, and family functioning. Piacentini and 
colleagues (32) showed that nearly 90 percent of 151 pediatric OCD 
patients had significant OCD-related impairment within at least one domain 
(i.e. social, academic, or home/family), and half of them reported 
significant dysfunction in all three domains. Valderhaug and Ivarsson (33) 
found similar functional impairment in a clinical Nordic sample. However, 
there were consistent gender and age differences, with girls having more 
severe functional impairment than boys, as well as adolescents having more 
severe functional impairment than children (33). Furthermore, avoidance 
behaviors may cause a great deal of suffering and impaired functioning 
(15, 16). OCD affects a young person’s ability to learn in school, and a 
register-based study with sibling controls has shown that OCD is associated 
with decreases in educational attainment (4). 
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Family involvement 
Families often accommodate to the OCD symptoms in many different ways. 
Parents and siblings facilitate avoidance or become involved in the 
child/adolescent’s symptoms, for example, by checking that doors are locked 
or all electric appliances are turned off, or by repeatedly answering reassurance 
questions from their child/adolescent. Another way of involvement is that 
parents or siblings carry out everyday tasks according to the child’s request, 
which are ruled by the obsessions (34-36). Family members often modify their 
social life based on the young person’s OCD symptoms, for example by not 
leaving home, not inviting guests home, or changing their routines and 
activities. Pediatric OCD may also have economic consequences, as about half 
of the mothers and one third of the fathers in one study reported occupational 
impairment due to their child’s OCD symptoms (37).   
Quality of life 
Quality of life (QoL) in pediatric OCD is notably lower than in a general group 
of children and adolescents (38, 39), although this improves for those who 
respond to CBT treatment (39, 40). In childhood, OCD is not only burdensome 
for sufferers but also for their families. A recent study of burden in caregivers 
to young people with OCD showed that the former’s QoL was also decreased, 
being negatively affected by the latter’s OCD (41).   
Sleep-related problems 
OCD symptoms may have a direct impact on sleep, as time-consuming rituals 
at bedtime lead to insomnia. Some children and adolescents do not want to 
sleep in their own bed due to obsessions that provoke anxiety. Moreover, 
sleep-related problems (SRPs) such as nightmares, insomnia, sleeping more or 
less than others, and increased fatigue are common. Approximately 70% of 
children and adolescents with OCD have one or more SRPs (42-45), which 
may be associated with greater dysfunction, impairment, and poorer response 
to CBT. SRPs adversely affect the child’s well-being and ability to participate 
in CBT, although when CBT treatment for OCD is possible, most children’s 
SRPs improved (45). 
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Comorbidity 
The co-occurrence of other psychiatric disorders in pediatric OCD is common, 
and clinical studies suggest that 40-86% of children have such comorbidities 
(8, 30, 46-49). The most common co-morbidities are developmental disorders 
(i.e. ADHD, tic disorders, and autism spectrum disorders), anxiety disorders, 
and depression (47). Furthermore, some OCD-related disorders occur more 
frequently in young people with OCD, such as BDD (11.7%) and skin-picking 
(16.7%). Some of the comorbid diagnoses have symptoms that are similar to 
those of OCD, both in function and structure (50).  
The presence of co-morbidity may aggravate and interfere with the OCD 
treatment (51). Clinical studies indicate that poorer treatment outcome is often 
associated with the occurrence of comorbid disorders (46, 52). Given the high 
rates of comorbidities, it is important to diagnose any comorbidities and be 
aware of the potential impact they may have on treatment response. In some 
complex cases, it may be necessary to treat and make adaptive interventions in 
the child’s environment to stabilize the comorbid disorder before starting the 
OCD treatment (53, 54) 
Etiology 
OCD has a heterogeneous etiology, and the exact causes and underlying 
pathogenesis of the disorder are not well understood. It appears that the 
condition might be caused by a combination of genetic, neurological, 
behavioral, cognitive, and environmental factors. Several candidate gene 
association studies have been conducted but have provided only modest 
insights. Most candidate genes have been related to the serotonin, dopamine, 
and glutamate neurotransmitter systems (55), although no single gene has been 
identified as the cause of OCD (56). A review of twin-studies of children and 
adolescents suggest that OCD symptoms are inherited, with an influence of 
genetic factors of approximately 40 % (57).  
It is conceptualized that in a small subset of pediatric OCD patients with an 
unusually abrupt and severe onset, OCD symptoms can be triggered by an 
autoimmune reaction, which causes an inflammation and dysfunction in the 
basal ganglia. This phenomenon is termed PANDAS (pediatric autoimmune 
neuropsychiatric disorders associated with streptococcal infection) when it is 
associated with streptococcal infection, and termed PANS (pediatric acute-
onset neuropsychiatric syndrome) or CANS (childhood acute neuropsychiatric 
symptoms) when it is presumed to result from a variety of disease etiologies 
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(post infectious, autoimmune, and neuroinflammatory disorders to toxic, 
endocrine, or metabolic disorders). However, the etiology of these conditions 
(i.e. PANS/PANDAS/CANS) remains unknown, and need to be further 
investigated before their place in clinical work can be decided (58).  
According to learning theory, people in the pathogenic pathway to OCD start 
to associate certain objects or situations with distress and then learn to avoid 
those things or to perform compulsions to reduce the distress. This reinforces 
both these behaviors and cognitions, and once the connection between an 
object and the feeling of distress becomes established, they become more 
engrained. Thus, people with OCD increasingly begin to avoid that object and 
the fear it generates, rather than confronting or tolerating the fear (59) 
However, little evidence indicates that OCD etiology is caused by such factors, 
although they seem to be vital with regard to the process leading to worsening 
of symptoms to a clinical level of severity. 
Figure 1. The theoretical basis of obsessive–compulsive behavior
(57). Reprinted with permission from Nature Reviews. 
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Cognitive risk factors 
The cognitive theory focuses on how people with OCD misinterpret their 
thoughts in a way that puts them at higher risk of OCD. Most people have 
unwelcome or intrusive thoughts at certain times, but for individuals with 
OCD, the importance of those thoughts are exaggerated. As long as the 
individual with OCD interprets these intrusive thoughts as disastrous and true, 
they will continue the avoidance and ritual behaviors (60). There is a 
discussion whether stress is an independent cause of pediatric OCD, or just a 
nonspecific factor that can have an adverse effect on the OCD symptoms. One 
study has demonstrated that there does not seem to be an association between 
pediatric OCD and serious negative childhood experiences or traumatic 
attachment experiences (61). Thus, it seems unlikely that such stressful event 
has a major influence. 
Course 
There is little known about the naturalistic course of untreated pediatric OCD. 
Moreover, there is deficient knowledge about the long-term outcome of 
evidence-based treatments. In the long run, OCD tends to have a fluctuating 
and often chronic course (40-60%) (62), and even studies of samples with 
appropriate treatment indicate a persistent risk for a chronic course and 
relapses of OCD leading to life-long suffering (26, 52, 62).  For those with 
remaining OCD symptoms, the level of these symptoms seems to wax and 
wane over time between a subclinical and a clinical level (63).  
Studies in adults indicate that OCD is a lifelong disorder, with high risk of 
relapse after treatment (64, 65). The longest follow-up study (over 40 years), 
consisted of a sample of 144 adults with OCD. Approximately half of the 
sample continued to have clinically significant symptoms decades later, and a 
third of them fulfilled the criteria for OCD (64). Studies of adults show that 
achievement of full remission during follow-up (5-15 years) after treatment, 
defined as an absence of OCD-symptoms, reduces the risk of relapse 
considerably (65, 66). Longer illness duration and more severe level of OCD 
symptoms have been found to increase the risk of a sustained chronic course 
in adults (67). Therefore, it is inferred to be of importance that treatment is 
given to prevent chronicity from occurring as well in pediatric OCD.  
Individuals with childhood onset OCD appear to have a more promising 
prognosis than OCD with adult onset, as 44% of the children had remitted by 
early adulthood (68). On the other hand, a majority (50-80%) of the adults with 
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OCD had pediatric onset of symptoms (27). There are a number of studies that 
have examined the long-term outcomes of pediatric OCD. A meta-analysis 
based on 16 studies (with follow-up periods ranging from 1 to 15.6 
years) showed persistence rates of 41% for full OCD and 60% for 
subclinical or full OCD. Longer duration of OCD at baseline was a 
predictor of persistent OCD at follow-up (52). The results were limited in 
that the included studies varied substantially by study types and lengths of 
treatment. Furthermore, only a few of the included studies had a 
prospective design and there was a lack of repeated assessments.  
In a randomized controlled trial of sertraline with an open extension of 
the treatment, half of the participants were in remission one year after 
treatment (69). A seven-year follow-up of a randomized controlled trial 
evaluated the stability of family-based CBT delivered individually or in a 
group format, and found remission rates of 79% for individual CBT and 
95% for group CBT after seven years (70). There are problematic 
weaknesses in the extant long-term follow-up studies, including a large 
variation in the time of the follow-up (1–11 years) (71, 72), small sample 
sizes (n<77) (31, 70, 73), and a large number of drop-outs from the 
follow-up (above 50%) (70-73). Moreover, in naturalistic follow-up 
studies, participants commonly receive mixed treatments (31, 71, 
72). All these are serious confounders and consequently lead to difficulties 
in the interpretation of the results. 
Evidence-based treatment of pediatric OCD 
Up until the 1980s, OCD was considered to be an untreatable condition. 
However, since the first report of useful treatment (74), knowledge 
has increased markedly, and the opinion today is that there are effective 
evidence-based treatments available. Current international clinical 
guidelines (13, 75) recommend CBT with exposure and response 
prevention (E/RP) as the first line of treatment for children and 
adolescents with OCD. SSRIs are recommended as a second line of 
treatment if the young person refuses to or is unable to participate in CBT, 
or when the response to CBT treatment is insufficient (5). More detailed 
information about the treatment conditions is provided below, along with 
strategies employed when OCD persists even after combined treatment with 
CBT and SSRI.  
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CBT 
A number of manuals for the treatment of pediatric OCD have been published, 
and several studies have investigated the efficacy of such treatment (8, 76, 77). 
Meta-analyses have shown moderate to large effect sizes for CBT, with 
moderate to high response rates to treatment (6, 7, 9, 78).  
A major component of CBT are psychoeducation, cognitive strategies, E/RP, 
and relapse prevention. Psychoeducation includes information about OCD and 
CBT, and it is helpful to use metaphors and analogies to explain exposure, 
therapeutic relation, and so on. An example of an analogy is describing distress 
as a “false alarm” (79). Rosa-Alcázar and colleagues (80) have shown that a 
manual based on multicomponent treatment comprising E/RP, cognitive 
strategies, and relapse prevention is the most favorable in pediatric OCD. E/RP 
involves in vivo exposure to the obsession provoking stimulus (which could 
be a situation/object/person, e.g. touching something that triggers the intrusive 
obsession about dirt and germs), and ritual prevention (when the person 
refrains from performing the compulsions, e.g. not washing despite the 
obsessions). Exposure is performed gradually and is individually adapted to 
each patient. It is of importance that the clinician emphasizes that the 
overarching goal is to gain long-term symptom remission by strengthening 
inhibitory learning rather than achieving short-term anxiety reduction (81).  
In a recent evidence-based update of psychosocial treatment, Freeman et al. 
(82) found that family support during CBT is well-established and is of great 
importance for enhancing the treatment outcome. Family support has been 
evaluated in a number of studies (83-86), yet the character and extent of family 
involvement differs between them. Thus, the amount of family involvement 
needed for optimal treatment outcome in pediatric OCD is still unclear (82). 
Furthermore, a number of modified ways to deliver CBT, including intensive 
and technology-based methods, have been evaluated, and the results are 
promising and seem to be effective (82, 87).
Pharmacotherapy 
Some children and adolescents may not participate in CBT or do not receive 
enough benefits from the CBT treatment, and thus are in need of other 
interventions. SSRIs are recommended as the first-line drug treatment for 
pediatric OCD (6, 7, 13, 75), and have a substantial evidence base but with a 
moderate effect size (5). If OCD symptoms increase excessively during CBT, 
SSRIs may need to be given in addition to CBT to improve the child’s ability 
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to cope with exposures during CBT (13). Switching to SSRIs may also be 
indicated if the young person is unable or refuses to participate in CBT (5, 9, 
78, 88). 
In Sweden and Denmark, sertraline and fluvoxamine are approved for 
pediatric OCD, whereas in Norway only sertraline is approved. Both response 
and adverse effects vary widely in young people treated with SSRIs for OCD, 
and so patients should be monitored weekly, then biweekly and then every 
month to every third month, to evaluate their response to the treatment and any 
adverse effects. Many of the latter may decrease over time, although some do 
not and may lead to fore-shortened treatment (69, 89).  
Treatment at non-response to initial treatment 
There are other “off-label” options when initial pharmacotherapy fails to bring 
symptom relief. Clomipramine, a tricyclic antidepressant, has evidence for its 
efficacy, but due to its adverse event profile should only be given in 
exceptional cases to young patients. Another option is augmenting SSRIs with 
second generation of antipsychotics (SGA), such as aripiprazole or 
risperidone, although the evidence for these treatment strategies is limited (90). 
In the recent Swedish national guidelines, augmentation with risperidone and 
aripiprazole to SSRIs has the lowest priority (10), meaning that it “may be 
offered as an exception” (91).  
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AIM 
The overall aims of this thesis are to systematically and prospectively 
investigate the long-term course of pediatric OCD and the outcome following 
treatment, in accordance with the Clinical Guidelines for pediatric OCD. The 
more specific aims of the thesis are to:  
• Present the clinical features and background factors of pediatric
patients with OCD (Study I)
• Describe the naturalistic treatment of a cohort of pediatric patients
with OCD (Study I)
• Examine how the children and adolescents psychosocial functioning
is affected by OCD (Studies I and II)
• Investigate if there are changes in depressive symptoms over time
(Study II)
• Examine the remission rates (defined as a total score of 10) and
response rates (defined as  15) on the Children’s Yale–Brown
Obsessive–Compulsive Scale (CY-BOCS) (Studies I, II, and III)
• Investigate whether response to the initial CBT in a stepped-care
model is an important indicator of outcomes after three years (Study
III)
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METHOD 
In this thesis, two different cohorts of children and adolescents with a 
diagnosis of OCD according to the DSM-IV-TR (American Psychiatric 
Association, 1994) were studied.  
Studies I and II are consecutive projects that employ the same cohort and can 
be viewed as naturalistic, prospective studies of the long-term outcome in a 
clinical sample of pediatric OCD patients.  
Study III, or The Nordic Long-term OCD Treatment Study (NordLOTS), was 
an effectiveness study of a stepped-care model with three treatment steps and 
a long-term follow-up. In this thesis, data are presented from the two- and 
three-year follow-ups. Data from the three treatment steps and one-year 
follow-up will not be reported in this thesis, but an overview of the study and 
a summary of step 1, step 2, and the one-year follow-up are described in paper 
III and the thesis.  An overview of the participants in Studies I-III is provided 
in Table 2. 
 
 
 
 
 
Table 2. Overview of participants in the two studied cohorts. 
Note: CY-BOCS= Children’s Yale-Brown Obsessive-Compulsive Scale, SD= 
Standard Deviation 
Studies I and II Study III 
Participants (n) 109 269 
Age (years) 5-17 7-17
Age, mean 12.9 12.8 
Gender (female/male (%)) 56/44 51/49 
CY-BOCS baseline (SD) 23.0 (6.1) 24.6 (5.1) 
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Measures 
The following measures were used for diagnostic work-up, inclusion of 
patients, and the assessment of treatment outcome. All measures were 
available in the Swedish language. Measures used in Study III were also 
available in Danish and Norwegian. 
The Kiddie Schedule for Affective Disorders and Schizophrenia – Present 
State and Lifetime Version (K-SADS–PL) (Studies I, II, and III)  
The K-SADS-PL is a semi-structured diagnostic interview for psychiatric 
disorders based on the DSM-IV, and was used as a diagnostic assessment at 
baseline. Diagnoses can be classified as “certain,” “in remission,” “possible,” 
or “not present.” 
In these studies, only OCD diagnoses and comorbidity classified as “certain” 
were included (92, 93). The K-SADS-PL has shown good interrater reliability 
(98%) (93) and an excellent interrater reliability in the Nordic countries (94). 
Furthermore, it has excellent convergent and divergent validity for child 
psychiatric disorders in a Nordic pediatric sample (92, 94, 95).  
The Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) 
(Studies I, II, and III)  
The CY-BOCS is a widely used, clinician-administrated, semi-structured 
interview that measures the current severity and presence of OCD symptoms. 
OCD severity is estimated separately for obsessions and compulsions based 
on: time consumed, level of distress, interference/impairment, resistance to 
OCD- symptoms, and degree of control over OCD-symptoms. It yields 
separate severity scores for obsessions and compulsions (0-20), adding up to a 
total score ranging from 0 to 40 (96). The CY-BOCS has shown good 
psychometric properties (53, 96, 97). In the NordLOTS sample, interrater 
agreement as measured by the intra-class correlation coefficients (ICCs) were 
0.92 (95% CI= 0.78–0.97) for the total score (98). 
The CY-BOCS is the primary outcome measure and also used to develop 
categorical treatment response, defined as a CY-BOCS total score of ≤15 and 
clinical remission as a CY-BOCS total score of ≤10 (76, 98).   
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The Clinical Global Impression-Severity (CGI-S) (Studies I and II) 
The CGI-S is a seven-point brief clinician rating of psychopathology severity, 
with ratings ranging from 0 (no illness) to 6 (extremely severe illness) (99, 
100). This clinician-rated scale has been extensively used in treatment studies 
of OCD in children and adolescents (69).  
The Children’s Global Assessment Scale (CGAS) (Studies I and II) 
The CGAS is an overall rating of the overall global functional ability due to 
psychiatric disorders. It is rated by the clinician on a numeric scale from 1 to 
100, with a higher score indicating better functional ability (101, 102). The 
scale has shown good inter-rater reliability with ICCs of 0.73 in clinical 
settings (103). Furthermore, both discriminant and concurrent validity has 
been demonstrated (102). 
The Autism Spectrum Screening Questionnaire (ASSQ) (Studies I and II) 
The ASSQ is a 27-item parent-rated form, here used as a dimensional measure 
of the presence of autism spectrum symptoms. The internal consistency of the 
ASSQ total score has shown to be α = 0.86 (104).   
The Child Behavior Checklist (CBCL) (Studies I and II) 
The CBCL is a widely used 113-item parent-report assessing a wide range of 
behavioral and emotional problems in children. Moreover, a child’s skills 
regarding activities, social relationships, and school performance are reported. 
Parents rate items on a three-point scale (0 = not true, 1 = somewhat or 
sometimes true, and 2 = very or often true), which has established 
psychometric properties across a variety of clinical and non-clinical 
populations REF. The CBCL has shown a mean test-retest reliability between 
0.95-1.00 and internal consistency from α  = 0.78 to α  = 0.97 (105). 
The Children’s OCD Impact Scale (COIS) (Studies I and II) 
The COIS is a 58-item self- and parent-report that measures the impact OCD 
has on the psychosocial functioning of children and adolescents at home and 
in social and academic situations (106). Every item is rated using a four-point 
Likert scale ranging from 0 to 3 (0 = not at all, 1 = only a little, 2 = pretty 
much, 3 = a lot). The children/adolescents and their parents both rate the 
difficulties experiences when performing their daily activities due to OCD.  
The parent and child versions of the COIS have demonstrated good internal 
consistency, as well as construct and convergent validity (32, 33).  
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The Child Depression Inventory (CDI) (Studies I and II) 
The CDI is a self-reported 29-item measure that assesses the symptom severity 
of depression based on the DSM-IV in children and adolescents (107). The 
CDI are based on DSM-IV diagnostic criteria for major and minor depression. 
Every item is rated using a three-point Likert scale (0 = not present, 1 = 
present/mild, 2 = present/obvious) (107, 108).  
Psychometric studies have demonstrated adequate internal consistency 
(Cronbach’s a = 0.71 to 0.89), test–retest reliability (r=0.74 to 0.83), and 
convergent and divergent validity (107). A Swedish version was used in the 
studies that had shown adequate reliability in a normative study (109).  
Wechsler Intelligence for Children (WISC III). 
The WISC III is an intelligence test for children and adolescents aged 6–16 
years. The scale is individually administrated and consists of  different subtests 
divided into verbal scales and performance scales (110). 
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Study I. Treatment and 12-month outcome of children 
and adolescents with obsessive–compulsive disorder: 
A naturalistic study 
Participants 
The study population of Study I, consists of 109 children and adolescents with 
a primary diagnosis of OCD, recruited at a specialized pediatric OCD clinic 
for out-patients in West Sweden. Participants were either referred from local 
Child and Adolescent Psychiatry units (50%) or self-referred by their parents 
(50%). All were invited to participate in the study if they had an initial 
assessment during the research period from January 2001 through December 
2005 and fulfilled the inclusion criteria. No exclusion criterion was applied. 
Inclusion criteria: 
• Primary diagnosis of OCD according to criteria in the Diagnostic and
Statistical Manual of Mental Disorders, fourth edition, Text Revision
(DSM-IV-TR);
• Was in need of and accepted treatment for OCD.
During the research period, 158 patients were assessed, 140 of whom had a 
primary diagnosis of OCD, whereof 114 accepted treatment. In total, 109 
children and adolescents gave their consent to participate in this research. The 
mean age of the participants at baseline was 12.9 years (range 5–17 years). 
Gender distribution was slightly uneven, with 61 girls (56%) and 48 boys 
(44%). A flowchart of the studies I and II is presented in Figure 2.  
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Figure 2. Flowchart over the studies I and II. 
 
 
Assessed for eligibility in the clinic between January 2001 and December 2005 (n=158) 
Excluded (n=44) 
• No OCD (n=18 )
• No treatment in the clinic (n=26)
Invited to participate in the naturalistic study (n =114) 
Included in the study (n=109) 
Declined (n=5) 
Completed 1-year 
follow-up assessment 
(n=85) 
Completed 2-year 
follow-up assessment 
(n=81) 
Completed 3-year 
follow-up assessment 
(n=67) 
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Procedure 
All children and adolescents (11 years old), together with their parents signed 
a written informed consent to participate in the study. Clinical comprehensive 
assessments were done at baseline prior to treatment. Diagnostic assessments 
for determining a primary diagnosis of OCD and any other psychiatric 
comorbidity were performed using KSADS-PL (93). The diagnostic 
evaluations were performed by an experienced child psychiatrist or a resident 
physician supervised by the experienced child psychiatrist. Severity and 
occurrence of OCD symptoms was assessed by a therapist in the team 
(including specialist nurses in psychiatric care, social worker, licensed 
psychotherapists, psychologists and child psychiatrist) using the CY-BOCS 
and CGI. Psychological assessments of the children and adolescents were 
conducted by a psychologist using the WISC III.  Furthermore, baseline 
assessments included several self- and parent questionnaires, assessing 
assessment of OCD related functional impairment (COIS), symptoms of 
depression (CDI), autism (ASSQ) and general psychiatric symptoms (CBCL). 
These measures were given out by the therapist. 
All 109 children and adolescents were invited to participate in the follow-up 
assessments. The outcome assessments followed a fixed windows scheme, six-
month and one-year following the baseline assessments. Follow-up 
assessments was performed by an independent rater, a therapist at the clinic 
whom was not responsible for the patient’s treatment. The CY-BOCS, COIS 
and CGI was used as outcome measures at follow-up assessments.  
Treatment 
The treatment was based on the current clinical guidelines for treatment of 
pediatric OCD and individually adapted for each patient (111). Appropriate 
adaption of the treatment was conducted, based on the child’s age, 
developmental maturity and the presence of any psychiatric comorbidity. The 
first choice of treatment was CBT with E/RP, which except for exposures with 
response prevention included psychoeducation and relapse prevention as well. 
Each patient had two therapists in charge, who alternated to participate in the 
CBT sessions. In most cases the CBT were administrated as home-based 
treatment (72.5%), although some were offered at the clinic (27.5%). 
Pharmacotherapy with SSRI was used as single treatment when the participant 
rejected to or cannot participate in the CBT treatment. Moreover, when the 
CBT response was insufficient, SSRI was used as combined treatment to 
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enhance CBT. In case of insufficient effect following treatment with an SSRI 
plus CBT, augmentation with an SGA was used. 
Statistical analysis 
The total sample of 109 was included in analyses. Initial analyses compared 
the baseline demographic and clinical characteristics between the two genders. 
Pearson’s χ2 test was used for the analysis of categorical variables and one-
way analysis of variance (ANOVA) for continuous measures. When 
comparing between participants with missing data and those with no missing 
data, we identified no significant differences. Therefore, in subsequent 
analyses, data were assumed to be missing at random.  
The primary outcome measure was a change in the CY-BOCS total score, and 
as a secondary outcome measure we used the change in total score of COIS-
C/P. The scalar total scores of treatment outcome measures were analyzed 
using linear mixed-effects models (LMEs). The tests were two-tailed, and a p-
value of less than .05 was considered to indicate statistical significance. No 
multiple imputations for missing values were made prior to the LME analysis, 
as simulation studies have shown that LME models deal with missing data in 
an appropriate way (Peters et al., 2012). However, multiple imputation was 
used to replace missing data before generating and analyzing categorical 
outcome data. A total of 10 data sets were generated to make the estimates. 
The outcomes were combined using Rubin’s rules (112). 
IBM SPSS 21 was used to perform the statistical analyses (113). 
Ethics 
Ethical approval for was granted by the internal review board (IRB) in 
Gothenburg, Dnr Ö 373-02. 
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Study II. A solid majority remit following evidence‑based 
OCD treatments: a 3‑year naturalistic outcome study in 
pediatric OCD 
Participants 
In total, 109 children and adolescents with a primary diagnosis of OCD were 
recruited in Gothenburg, Sweden. The participants were the same as those who 
participated in Study I. A flowchart of the study is presented in Figure 2. 
Procedure and Treatment 
If participants were in need of further treatment during the period from the 
one-year follow-up to the three-year follow-up, they were offered additional 
periods of treatment based on the current clinical guidelines for treatment of 
pediatric OCD, as described above in Study I. The outcome assessments 
following the fixed window scheme were conducted two and three years 
following the baseline assessments. Follow-up assessments were performed 
by an independent rater, who administered both interviews and questionnaires. 
Statistical analysis 
The primary outcome measure was a change in the CY-BOCS total score, and 
as a secondary outcome measure we used the change in the total score of 
COIS-C/P and CDI. The scalar total scores of treatment outcome measures 
were analyzed in the same way as described in Study I. Multiple imputation 
was used to replace missing data before analyzing categorical outcome data. 
Before multiple imputation, missing data from the two- and three-year follow-
ups were analyzed for randomness using ANOVA. Comparisons were made 
based on OCD-severity at baseline, age, gender, age of OCD onset, and OCD 
severity at follow-up timepoints (six months, one-year, and two-years) 
between participants with missing data and those with non-missing data. None 
of these comparisons showed any significant differences, thus data were 
assumed to be missing at random. The prerequisites for using multiple 
imputation were consequently met. A total of 20 data sets were generated to 
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make the estimates. The outcomes were combined using Rubin’s rules (112), 
and statistical analyses were performed in IBM SPSS 22 (114).  
Ethics 
Ethical approval for was granted by the internal review board (IRB) in 
Gothenburg, Dnr Ö 373-02. 
Study III Treatment Gains are Sustainable in Pediatric 
Obsessive-Compulsive Disorder: Three-Year Follow-Up 
from the NordLOTS 
The Nordic Long-term OCD Treatment Study (NordLOTS) is a collaboration 
between Swedish, Norwegian, and Danish researchers and clinicians. It is a 
multicenter study, in which a total of 20 clinics cooperated, including both 
general community CAP units and specialized OCD-clinics. There were five 
main study sites that cooperated in the study: Gothenburg and Stockholm in 
Sweden, Aarhus in Denmark, and Oslo and Trondheim in Norway 
Participants 
The study population of Study III comprised of 269 children and adolescents, 
all of whom had been included in the NordLOTS between September 2008 
and June 2012. The last follow-up data were collected in December 2015. 
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Inclusion criteria: 
• Primary diagnosis of OCD according to criteria in the DSM-IV-TR
• CY-BOCS total severity score of ≥16
• Age range of 7-17 years
• Patients with ADHD were included if they were stabilized on
medication for at least three months
Exclusion criteria: 
• Comorbid disorders with higher treatment priority than OCD (i.e.
psychosis and depression with suicidality)
• Mental retardation or autism spectrum disorder (although PDD-NOS
was allowed if the CGI score for this was  3)
• Treatment for OCD with either CBT or SSRI within the last six
months prior to inclusion
• Parent or child could not understand the language in the country
where the study was carried out
The most common exclusion criteria were: did not meet diagnostic criteria for 
OCD, or did not have sufficient OCD severity (i.e. CY-BOCS 15). The 
included participants had an average age of 12.8 years (ranging from 7 to 17 
years; see (8). A flow diagram of the NordLOTS is presented in Figure 3. 
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Figure 3. Flow diagram of The Nordic Long-term OCD Treatment Study 
(NordLOTS) 
 Included in the NordLOTS  (N=269)
Intervention: 13 weeks of CBT 
• Completed intervention (n=241)
• Drop out (n=28)
CBT Responders (n=177
(CY-BOCS severity score ≤ 15)
CBT non-responders (n=64)
(CY-BOCS severity score > 15)
• Declined randomization (n=10)
Randomized (n=54)
Allocated to sertraline (n=26)
• Completed intervention (n=15)
• Drop out  (n=7)
• Did not received allocated intervention (n=4)
(responders at reassessment due to treatment
delay)
Allocated to continued CBT (n=28)
• Completed intervention (n=21)
• Drop out (n=7)
Included in the present study 
Follow-up (ITT) 
(n=269) 
Completed 6-month follow-up
(n=158)
Completed 1-year follow-up
(n=186)
Completed 2-year follow-up
(n=169)
Included in the Analysis (ITT)
(n=269)
Completed 3-year follow-up
(n=168)
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Procedures 
Extensive assessments were conducted at baseline prior to treatment, and all 
young people and their parents participated in the assessments. To make the 
OCD diagnosis and possible comorbid psychiatric diagnoses, a semi-
structured diagnostic interview was conducted using the KSADS-PL. The CY-
BOCS was used to measure the severity of OCD symptoms. 
All 269 study participants were invited to take part in the follow-up 
assessments. The outcome assessments followed a fixed window follow-up 
scheme of two- and three-years post-treatment of the first step CBT. The CY-
BOCS was used as an outcome measure at the follow-up assessments. The 
assessments were performed by an independent rater, who was a therapist at 
the clinic but not responsible for the patients’ treatment. 
Treatment 
The first-step of CBT was based on a Nordic manual for pediatric OCD (79). 
A former manual by March and Mulle (115) was translated into Nordic 
languages and adapted to Nordic conditions. Furthermore, the manual was 
extended with additional family interventions, from a customized version of a 
manual by Piacentini. The main parts of the CBT included psychoeducation 
about OCD and CBT, goal formulation, exposure and response prevention, and 
relapse prevention. All included participants were offered 14 weekly sessions, 
with a minimum requirement of at least seven sessions. An overview of the 
CBT treatment sessions is presented in Appendix 1. 
The CBT sessions were audio taped and treatment fidelity was evaluated 
regard to three categories; manual adherence; relationship competence, and an 
aggregated evaluation of the session. The treatment fidelity was found to be 
very good (8, 98). 
Non-responders to the first-step CBT (CY-BOCS total score 16 post 
treatment) were randomly assigned to 16-week extended treatment of either 
continued CBT (10 sessions using the same CBT manual) or pharmacotherapy 
with sertraline (6 sessions), according to a pharmacotherapy manual based on 
the manual used in the POTS study (76). An overview of the pharmacotherapy 
sessions is presented in Appendix 2. 
At non-response to the second-step CBT, participants were offered 
pharmacotherapy with CBT and SSRI. A third step of the treatment for those 
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with non-response to the second step of treatment was based on 
pharmacotherapy augmenting aripiprazole (an SGA) to sertraline. Only three 
participants were offered and accepted this treatment. Thus, this extension has 
not been analyzed nor published.  
 Figure 4. Overview of the NordLOTS study flow. 
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Statistical analysis 
The total sample of 269 participants was included in the analyses according to 
intent-to-treat (ITT) principles. Comparisons of the baseline demographic and 
clinical characteristics between two groups were performed: those who 
responded (n=241) and those who did not respond (n=64) to initial CBT 
treatment.  For analyses of categorical variables we used χ2 tests, and ANOVA 
was used to analyze the continuous measures.  
There was some attrition to the follow-up assessments, with 37.2% (n=100) at 
two-years follow-up and 37.5% (n=101) at three-years follow-up. None of the 
comparisons showed any significant differences between participants with 
missing data and those with non-missing data, with regard to the baseline CY-
BOCS total score, age of onset, gender, age, socioeconomic status, and 
estimated treatment outcomes. Consequently, we assume that data were 
missing at random in subsequent analyses, and the requirements for using 
multiple imputations are consequently met.  
The statistical method we applied for the primary outcome of the CY-BOCS 
as a continuous measure was piecewise regression (116, 117). This method
was used to investigate the reduction of the primary outcome measure of the 
CY-BOCS total score during first-step CBT compared with the three-year 
follow-up period. The model estimates whether there is a change in outcome 
trajectory after a known occurrence, which in this study is posttreatment of 
the first-step CBT. The LME model was conducted and included two 
random effects (intercept and weeks since baseline) and two fixed effects 
(group of the first-step CBT response and interaction of time and group of 
response). Tests were two-tailed, and a p-value of less than .05 was 
considered to indicate statistical significance. 
Missing data were handled with multiple imputations with a sequential 
regression multivariate imputation algorithm (112), before analyzing the 
categorical outcome data. The imputation model included all baseline 
demographics, outcome measures, treatment indicators, stratification variables 
(sex and tic disorder), time in weeks, and all feasible predictors and 
moderators. 
In accordance with the guidelines, a total of 20 data sets were generated to 
make the estimates, confidence intervals, and p-values reliable (118, 119). The 
outcomes were combined using Rubin’s rules (112). Additional analyses of 
categorical outcomes were performed of those participating in the three-year 
follow-up assessment (n=168) as well. 
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Statistical analyses were performed in IBM SPSS 23 (120), except for the 
LME and multiple imputation of dichotomous outcome values that were 
conducted in SAS Statistical Software, Version 9.4 (121). 
Ethics 
Ethical approval was granted by the IRB in Gothenburg, Dnr 487-07, and by 
respective local IRBs in and Denmark Norway.  
Trail registration 
Clinical trial registration was conducted at www.controlled-trials.com; 
ISRCTN66385119 Nordic Long-term Obsessive-Compulsive Disorder (OCD) 
Treatment Study. 
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RESULTS 
Study I 
Initial analyses of the participants in study I (and II), compared the baseline 
demographics and clinical characteristics between gender. These results are 
presented in Table 3.  
 
 
 
 
 
 
 
 
Table 3. Pretreatment Demographics and Clinical Descriptive Statistics of 
Pretreatment Demographics and Clinical Descriptive Statistics of 
participants of study I and II. 
Variable Total Girls Boys p-value
N 109 61 48 - 
Age, year, mean (SD) 12.9 (2.6) 13.3 (2.4) 12.2 (2.6) .046a
Age of OCD onset, year (SD) 9.8 (2.9) 9.6 (2.9) 11.2 (3.0 .341a
CY-BOCS, mean (SD) 
   Total baseline 23.0 (6.1) 23.7 (5.6) 22.2 (6,6) ns.b 
   Obsessions baseline 11.6 (3,7) 12.0 (3.1) 11.1 (4.4) ns.b 
   Compulsions baseline 11.4 (3.3) 11.7 (3.1) 11.1 (3.5) ns.b 
CGI 4.2 (1.1) 4.2 (1.0) 4.2 (1.2) ns.b 
COIS child report 41.9 (30.3) 46.4 (31.0) 36.1 (28.7) ns.b 
COIS parent report 55.0 (32.5)  57.3(31.8) 51.9(33.5) ns.b 
CBCL total 43.0 (20.3) 42.8 (19.4) 43.2(21.7) ns. b 
    Internalizing 
     Externalizing 
14.7 (7.8) 
10.2 (8.5) 
15.4 (7.7) 
9.8 (7.4) 
13.8 (8.0) 
10.7 (9.8) 
ns.b 
ns.b 
ASSQ 7.5 (5.9) 6.9 (5.4) 8.3 (6.5) ns.b 
CDI 11.8 (9.0) 12.3 (9.0) 11.0 (8.9) ns.b 
CGAS 50.8 (10.3) 50.2 (8.8) 51.6 (12.0) ns.b 
WISC 100.6 (13.1) 100.2 (1.8) 101.2 (12.9) ns.b 
Note: Significant differences (p < .05) are indicated with boldface.  
a One-way Analysis of variance of groups b Pearson Chi-square of groups  
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The majority of the participants (95.4%) received CBT up to the one-year 
follow-up assessment, with an average of 14 sessions (range 1-42, Mdn 12). 
The CBT treatment was completed for most participants (55%) at that time.  
Five (4.6 %) participants were treated with SSRI only, either by their own 
choice or if they were unable to participate in the CBT. In total 54.1% of the 
participants were medicated with SSRIs at some stage prior to the one-year 
follow-up. However, there was substantial variation, as some were on 
medication when they came to the first assessments, some started during the 
process, and others terminated their medication usage during the first year. The 
most common drug was Sertraline, with a median daily dose of 100 mg. A 
minority of the participants (n=9, 8.3 %) received augmentation with SGA 
alongside their SSRI. Eight patients were as well treated as inpatients due to 
inadequate treatment response. 
The majority of the participants were assessed at the six-month (76.1%) and 
one-year (78%) follow-up. Analysis with LME of the CY-BOCS total score 
showed a significant reduction of OCD-symptoms across time (F 2, 
86.169=80.118, p < .001). The estimated CY-BOCS total score at baseline 
was 23.0 (95% CI 21.8–24.2) with a decrease from baseline to the one-year 
follow-up by an estimated average of 11.8 points. Figure 5 illustrates the 
estimated CY-BOCS severity scores over time for Study I and II. 
At the one-year follow-up, two out of three patients (67%) were responders 
(CY-BOCS 15) and almost half (47.7%) were in remission (CY-BOCS 10). 
Out of these, one-third (16.7% of the full sample) had a CY-BOCS total score 
of 0, meaning that they had no OCD symptoms. However, about one third 
(33%) of the total participants had continued moderate to severe OCD 
symptoms at the one-year follow-up, out of which 86% had continued therapy 
with CBT and/or SSRI at the one-year follow-up. Severity of OCD symptoms 
from baseline to the three-year follow-up (study I and II) are illustrated in 
Figure 6.  
Participants had improved their psychosocial functioning between the baseline 
and the one-year follow-up, according to both the self- and parent-ratings. 
Analyses with LME of secondary outcome measures with regard to 
impairment (COIS-C and COIS-P) showed significant reduction over time (F 
2, 65.739 18.014, p < .001 and [F 2, 77.433] 23.681, p < .001, respectively). 
Psychosocial functioning, the estimated COIS-C and COIS-P total scores from 
baseline to three-year follow-up (Study I and II) are illustrated in Figure 7.  
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Study II 
By the three-year follow-up, the participants had received 22 (SD = 19.1, Mdn 
=16) CBT sessions on average (distributed over 1-3 periods of treatment), 
including treatment during the first year. However, the majority (65%) of 
participants had only one period of CBT treatment with an average of 16 
sessions (SD = 15.9). Up until the two-year follow-up assessment, most 
participants (66%) had completed the CBT treatment, and at the three-year 
follow-up, only 10% of the participants were still receiving CBT. Moreover, 
at the three-year follow-up almost a third (32%) were on continuing 
pharmacotherapeutic treatment with an SSRI. One participant initiated 
combined treatment with SSRI and SGA and three received inpatient care 
during the second and third year after baseline.   
During the study, all participants were invited to each follow-up assessment. 
Three out of four participated (74.3%) in the two-year follow-up assessment, 
while 61.5% participated in the three-year follow-up. 
Analyses with the LME model of the longitudinal CY-BOCS total score 
revealed a significant reduction in OCD symptoms with a significant effect of 
time [F(4, 329.743) = 101.439, p < 0.001]. The estimated mean CY-BOCS 
total score at baseline was 23 (95% CI 21.8–24.2) and had decreased to 6.9 
(95% 5.2–8.7) at the three-year follow-up. Almost four out of five (78%) of 
the participants had at least a 35% reduction of the CY-BOCS total score at 
the three-year follow-up. The mean CY-BOCS total score reduction from 
baseline to the three-year follow-up was 64% (SD = 32.9). Estimated CY-
BOCS total scores are illustrated in Figure 5. 
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Figure 5. Estimated Children`s Yale-Brown Obsessive-Compulsive 
Scale (CY-BOCS) total scores, from baseline to three-year follow-up in 
children and adolescents (ITT, n=109) in study I and II, with 95% CI. 
Note: p < 0.001 
At the two-year follow-up, 56.9 % of the participants were in remission (CY-
BOCS total score  10), and the remission rate increased to 66.1% until the 
three-year follow-up.  Response to treatment based on a CY-BOCS total score 
of 15 at the two-year follow-up was 69,7%, which increased to 85.3% up 
until the three-year follow-up. There was no significant difference (p = .50) in 
remission status between those with mild (CY-BOCS 15) and those with 
moderate to severe OCD (CY-BOCS 16-40) at baseline. Severity of OCD 
symptoms from baseline to the three-year follow-up (study I and II) are 
illustrated in Figure 6.  
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Figure 6. Severity of OCD symptoms at baseline and at one-year, two-
year and three-year follow-up (Study I and II). 
The OCD impact on the participants’ psychosocial functioning was measured 
by the COIS-C/P, and was found to be reduced during the follow-up. 
Longitudinal analyses with LME showed significant reduction with an effect 
of time [F(4, 67.586) = 19.419, p < 0.001] on the COIS-C total score and with 
an effect of time [F(4, 81.447) = 26.382, p < 0.001] for the COIS-P total score. 
The estimated mean of the COIS-C total score at baseline was 41.3 (95% CI 
35.0–47.6), with a reduced score of 13.2 (95% CI 9.5–16.9) and 14.4 (95% CI 
9.4–19.5) at the two- and three-year follow-ups, respectively. The mean COIS-
P total score at baseline was estimated to be 54.4 points (95% CI 47.7–60.5) 
and was reduced to 20.7 (95% CI 15.9–25.6) and 16.6 (95% CI 11.4–21.8) at 
the two- and three-year follow-ups, respectively. Pairwise comparisons 
showed significant differences across time from baseline to the two- and three-
year follow-ups (p < .001) for self-ratings and parental ratings. However, there 
was no significant reduction of the impairment between the two- and three-
year follow-ups. Psychosocial functioning, the estimated COIS-C and COIS-
P total scores from baseline to three-year follow-up (Study I and II) are 
illustrated in Figure 7.  
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Figure 7. Psychosocial functioning, estimated Children’s OCD Impact 
Scale (COIS-C)/ (COIS-P) total scores from baseline to three-year 
follow-up (Study I and II). 
Longitudinal analysis with LME of self-reported depressive symptoms were 
measured with CDI, and revealed a significant effect of time [F(4, 57.160) = 
6.571, p < 0.001]. The estimated mean total score of CDI at baseline was 11.8 
(95% CI 9.9–13.7) with a reduced score of 7.7 (95% CI 6.1–9.2) at the two-
year follow-up, and a similar reduced score of 7.6 (95% CI 5.8–9.3) at the 
three-year follow-up. 
Study III 
Most participants (89.6%), completed the first step of treatment with 
manualized CBT, with 73.2% responding well to this first stage of CBT, 
including two additional responders not reported in original outcome paper, 
due to that data for these two patients were initially missing (8, 122). Non-
responders were randomly assigned to a 16-week second treatment stage, with 
some offered continued CBT (10 sessions) and others pharmacotherapy with 
sertraline. Approximately half of them (50% in the CBT group and 45.4% in 
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the sertraline group) responded well to the second step of treatment (123). The 
one-year follow-up of those who responded to the first step of CBT showed 
that the improvement that had been achieved was maintained, and that they 
continued to improve further during the first year after treatment (122). 
All 269 participants were invited to each follow-up assessment, with the 
majority participating in the two-year (62.8%) and three-year (62.5%) 
assessments. Pre-treatment demographics and clinical descriptions of the 
sample are presented in Table 4. 
Table 4. Pre-treatment Demographics and Clinical Descriptive Statistics 
(Study III). 
Variable Total Responders  
to first-step CBT 
 Non-responders 
 to first-step CBT 
p-value
n 269 177 64 - 
Age, year, mean (SD) 12.8 (2.7) 12.6 (2.8) 13.2 (2.6) .077a
Age of OCD onset, year (SD) 11.65 (2.99) 11.4 (3.05) 11.9 (2.92) .308a
   Female participants 138 (51.3) 84 (47.5) 37 (57.8) .156b
   Male participants 131 (48.7) 93 (52.5) 27 (42.2) 
Family status, n (%) 
   Parents living together 173 (64.3) 114 (64.4) 44 (68.8) .440 b 
   Divorced 91 (33.8) 59 (33.3) 20 (31.3) 
   Other 4 (1.5) 4 (2.3) 0 (0.0) 
CY-BOCS, mean (SD) 
   Total baseline 24.6 (5.1) 23.8 (5.0) 26.4 (5.3) .001 a 
   Obsessions baseline 12.3 (2.8) 11.9 (2.7) 13.1 (2.9) .005 a 
   Compulsions baseline 12.3 (2.7) 11.9 (2.6) 13.3 (2.7) .001 a 
Baseline comorbid disorders (K-SADS PL), n (%) 
   Any anxiety disorders 52 (19.3) 31 (17.5) 15 (23.4) .311 b 
   Any depressive disorder 10 (3.7) 4 (2.3) 4 (6.3) .129 b 
   ADHD 24 (8.9) 17 (9.6) 7(10.9) .836 b 
   ODD/CD 10 (3.7) 8 (4.5) 1 (1.6) .282 b 
   Tic 49 (18.2) 32 (18.1) 13(20.3) .708 b 
Number of co-occurring diagnoses, n (%) 
   None 163 (62.8) 110 (64.0) 36 (56.3) .130 b 
   1 62 (23.0) 39 (22.7) 16 (25.0) 
   2  25 (9.3) 14 (8.1) 11 (1.6) 
   ≥3 13 (4.9) 9 (5.2) 1 (1.6) 
Note: Significant differences (p < .05) are indicated with boldface. ADHD = attention-deficit/hyperactivity disorder; CD = conduct 
disorder; CY-BOCS =Children’s Yale-Brown Obsessive-Compulsive Scale; K-SADS-PL = Kiddie Schedule for Affective Disorders and 
Schizophrenia-Present and Lifetime Version; OCD =obsessive compulsive 
disorder; ODD = oppositional defiant disorder. 
a One-way Analysis of variance of groups of response and non-response to initial CBT differences.
b Pearson Chi-square of groups of response and non-response to initial CBT differences. 
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The longitudinal trajectories of OCD severity by CY-BOCS total score were 
investigated using LME models. Analyses of the ITT sample (n=269) showed 
a significant reduction of the estimated mean CY-BOCS total score from 
baseline 24.7 to the three-year follow-up 5.0 (p=.001). Analyses of those 
(n=177) who responded (CY-BOCS 15) versus those (n=64) who did not 
respond (CY-BOCS 16) to first-step CBT as a grouping variable, revealed a 
significant (p<.001) difference between the groups at the two-year assessment, 
although no significant (p=.998) difference was found at the three-year follow-
up. Furthermore, no significant difference was found (p=.169) between the 
extended treatment conditions of either CBT or pharmacotherapy with 
sertraline at the three-year follow-up.  
Treatment following the one-year follow-up was not directed by the study 
design, but any type of treatment that the participants received in between 
follow-ups was recorded. However, the study’s standard operating procedure 
prescribed how CBT booster sessions should be offered during the follow-up, 
and how extra treatment was to be offered at relapse. So even after the one-
year follow-up, any OCD-treatment was performed in accordance with the 
study manuals for CBT and pharmacotherapy, as far as possible.   
During the follow-up period (i.e. second and third years after first-step CBT), 
6% (n=16) of the patients relapsed (CY-BOCS 16) and received 
supplementary treatment. Five of the them were given additional CBT (6-17 
sessions) and the other 11 received pharmacotherapy with sertraline. At the 
three-year follow-up, only 4.8% (n=13) of all participants had continuous 
treatment with sertraline. One to five booster sessions of CBT were given to 
11.9% (n=32) of the participants, due to an increase of OCD-symptoms, but 
these patients did not fulfill the criteria for a relapse.  
Moreover, analysis showed a significant difference (p<.001) between those 
receiving further treatment (i.e., from initial CBT posttreatment – three-year 
follow-up) and those receiving no further treatment for OCD during the second 
and third years of the follow-up assessment period (i.e. following step 2 of the 
treatment). The estimated CY-BOCS mean score for those with no further 
treatment was 3.8 at the three-year follow-up, and for those with further OCD 
treatment the estimated CY-BOCS mean score was 7.8. 
Throughout the follow-up period, 11.2% (n=30) of the patients received 
additional treatment for psychiatric disorders other than OCD, such as 
medication for ADD/ADHD (6.7%, n=18), and CBT or medication for 
depression, oppositional defiant disorder, sleep disturbance, anxiety disorders, 
or trauma (4.5%, n=12).  
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The estimated CY-BOCS severity scores at different assessment points 
(baseline, posttreatment of first-step CBT, and all time points during follow-
up) for the total sample and divided in groups of responders/non-responders to 
first-step CBT are presented in Table 5. Figure 8, illustrates the estimated CY-
BOCS severity scores by response status at posttreatment following first-step 
CBT.
Table 5. Outcomes Across Follow-up Assessments Points. 
Mean SE 95% CI 
Lower Bound Upper Bound 
Total (n=269) 
   Baseline 24.7 0.32 24.1 25.3 
   Post CBT 10.9 0.44 10.0 11.7 
1-year FU 8.2 0.37 7.5 8.9 
2-year FU 6.6 0.36 5.9 7.3 
3-year FU 5.0 0.46 4.1 5.9 
Responders to first-step CBT (n=177) 
   Baseline 23.8 0.39 23.1 24.6 
   Post CBT 7.9 0.37 7.2 8.6 
1-year FU 6.1 0.34 5.5 6.8 
2-year FU 5.6 0.39 4.8 6.4 
3-year FU 5.0 0.52 4.0 6.1 
Non-responders to first-step CBT (n=64) 
   Baseline 26.6 0.74 25.2 28.1 
   Post CBT 19.4 0.75 17.9 20.9 
1-year FU 14.2 0.70 12.9 15.6 
2-year FU 9.6 0.85 8.0 11.3 
3-year FU 5.0 1.15 2.8 7.3 
Note: Estimations of CY-BOCS severity score based on linear mixed-effects model. Post first-step CBT was 
measured at week 13. CBT= Cognitive behavior therapy; CY-BOCS =Children’s Yale-Brown Obsessive-
Compulsive FU= Follow-up; SE= standard error.  
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Figure 8. Long-term outcome over three years. Estimated Children`s 
Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) total scores in 
children and adolescents (ITT, n=269), by groups of responders/non-
responders to the first-step CBT with a 95% CI.  
The estimated score of the overall impairment measured by CGAS at baseline 
was 54.0, with an increase during first-step CBT to 71.3. Analysis of the 
overall impairment found a significant (p<.001) increase from the 
posttreatment of first-step CBT to the three-year follow-up to an estimated 
score of 77.6, and with an average increase in functioning of 6.3 points.  
Moreover, 90% of the participants were rated as responders and 73% were in 
clinical remission at the three-year follow-up. Analyses of treatment response 
(CY-BOCS 15) and clinical remission (CY-BOCS 10) at this stage of the 
ITT sample (n=269) were based on imputed data. Additional analyses of those 
participating in the three-year follow-up (n=168) showed an outcome slightly 
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better than that for the ITT sample, in that 94% (n=157) of the patients were 
responders to treatment and the rate of clinical remission was 81% (n=136) at 
the three-year follow-up. Figure 9. Illustrates remission rates across the follow-
up period. 
 
Figure 9. Remission Rates Across Follow-up Assessments. 
Note: *p < .01 First-step CBT post-treatment responder status associated 
with increased likelihood of remission at post-treatment, 1, 2, and 3-year 
follow-up. CBT = cognitive-behavioral therapy, FU = follow-up. 
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DISCUSSION 
The focus of this thesis is to study the long-term course of pediatric OCD and 
its outcome three years following evidence-based treatment. The concept was 
to follow the children and adolescents prospectively and to investigate whether 
they improved over time with regard to symptom severity, impairment, 
psychosocial functioning, and depressive symptoms. Additional treatments 
received during the follow-up period was described. The study aimed to 
improve the knowledge about the long-term outcome of evidence-based 
treatments for pediatric OCD. This may hopefully contribute to the 
improvement of future treatment strategies.  
Main findings 
The overall findings of the three studies presented in this thesis suggest that 
most children and adolescents diagnosed with OCD have a positive long-term 
outcome following evidence-based treatment for pediatric OCD, based on 
expert consensus guidelines. The results are characteristic both for the 
individually adapted treatment based on the clinical consensus guidelines in 
Studies I and II as well as for the stepwise treatment procedure applied in Study 
III.  
OCD symptom severity 
In Study I, we found that a majority of young people with OCD had improved 
and had fully or partially recovered from the OCD-symptoms after one year 
after baseline assessments. These results are in line with other studies of 
pediatric OCD described in meta-analyses (78, 124). Our findings show a 
better outcome at the one-year follow-up where the mean CY-BOCS total 
scores of 11.2 compare favorably with the mean scores of 14.1 shown in 
another naturalistic long-term follow-up study (71). 
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Study II used the same sample as Study I, and results indicate that the 
improvements achieved after one year were maintained and that the young 
people with OCD were further improved during the extended follow-up period 
(i.e. second and third year after baseline assessment).  After three years, 66% 
of the patients were in remission, and approximately five out of six (85.3%) 
had responded to the treatment. However, 14.7% still had a persistent 
diagnosis of full OCD, whereof 14 (13.8%) had moderate severity and only 
one (0.9%) had severe OCD. These results are far better than those shown in 
previous long-term follow-up studies, where both remission rates (53%) (125) 
and response rates (67%) were much lower (125, 126). However, comparisons 
with other naturalistic studies are confounded by methodological issues: their 
wide range of follow-up periods (1-11 years); the age of the participants in 
their follow-up samples (11-28 years); and large variation of additional 
treatments received during the follow-up period (71, 72, 126). Despite the 
high degree of co-morbidity in our sample (48), response to treatment is 
more favorable than in other studies, as described in a meta-analysis of 
follow-up studies (52).     
The low age of the participants in our sample at follow-up may have affected 
our results, as higher rates of remission have been shown among young people 
versus adults with OCD have been shown (125). Furthermore, about one-third 
of our sample had ongoing OCD-treatment at the three-year follow-up. Among 
those with ongoing treatment at three-year follow-up, SSRI medication was 
used in most cases (32%), whereas two participants received a combination of 
CBT and SSRI, and four participants (3.7%) received CBT at the three-year 
follow-up. However, the rates of ongoing treatment in our cohort were lower 
in comparison with those described in a previous study of OCD (125). Our 
findings also differ from those of a UK-based study, where OCD was shown 
to take an episodic or more waxing and waning course, with a high risk of 
chronic OCD symptoms (71). The findings of previous studies indicate the 
need for us to follow up and assess patients into adulthood, in order to verify 
whether relapse rates rise in late adolescence or early adulthood. 
Study III is the first multinational and multicenter study of pediatric OCD, and 
remains the largest study that has systematically investigated the long-term 
outcomes of pediatric OCD with repeated assessment points over a three year 
follow-up period. The treatment was delivered in a stepped care model with 
those not responding to first-step CBT (14 weeks) being randomized to a 
second step with either continued CBT or pharmacotherapy with sertraline, 
both of which are viable treatments for CBT non-responders (123). Attrition 
was moderate, as we completed assessments at the clinics, with 63% and 62% 
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of the 269 participants returning for the two-year and three-year follow-ups, 
respectively.  
The main findings of the study were that three-fourths (73%) of the 
participants were in clinical remission (CY-BOCS≤10) at the three-year 
follow-up assessment, indicating a better long-term outcome of pediatric OCD 
as compared with that reported in previous studies (52). Furthermore, another 
17% had responded to treatment, even though they still had mild OCD 
symptoms (CY-BOCS=11–15), thus the overall response rate was 90% at the 
three-year follow-up. These results extend the findings reported in the one-
year follow-up of responders to initial CBT in the NordLOTS, where a large 
majority (92%) of participants remained in remission at the one-year follow-
up (122). Treatment gains were maintained and improved further during the 
follow-up period (i.e. second and third year after the first treatment step), in 
that the mean CY-BOCS total score at baseline of 24.7 had decreased to 5.0 a 
mean CY-BOCS score of after three years. These findings are characteristic 
both for those who responded well to initial CBT and for those who needed 
extended treatment with CBT or sertraline. Hence, the symptom level at the 
three-year follow-up did not appear to be influenced by either early response 
to treatment, the duration or the sequence of treatments. Those with more 
severe OCD symptoms at baseline were more likely to get extended treatment, 
however the differences in severity levelled out over time. Furthermore, a 
minority of the participants (6%) received treatment for OCD (CBT and/or 
sertraline) during the follow-up period, and in addition 11.9 % had 1-5 booster 
sessions. Thus, approximately 5% of participants were receiving ongoing 
OCD-treatment with sertraline at the three-year follow-up. These rates of 
ongoing treatment were much lower than those described in a previous study 
of OCD (125), and also lower than those in Study II.  
The substantial stability of treatment gains and long-term rates of mild OCD 
(17%) or chronic moderate–severe OCD (10%), as demonstrated in Study III, 
are much better than the pooled mean persistence rate for full OCD of 41% 
reported in a meta-analysis by Stewart et al. (52). Our findings are in 
accordance with those of O’Leary et al. (70), who assessed patients seven 
years after they received CBT. However, their result could be confounded by 
methodological issues, such as more than 50% attrition to follow-up, and that 
most of the follow-up assessments were performed by telephone interviews 
(70); in contrast, our data were collected via interviews conducted in person at 
the clinic. Furthermore, the results in Study III are in accordance with and even 
slightly better than the long-term remission rate of 66% and response rate of 
85% that were demonstrated in Study II 
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Taken together, these three studies may indicate that when good quality CBT 
is used in pediatric OCD, the long-term outcome is correspondingly good. 
Furthermore, our findings of the long-term outcomes in children and 
adolescents are far better than those described in adult samples (29, 64). The 
duration between onset of OCD and start of treatment could be more than 17 
years in adult samples, while the mean duration between onset of OCD and 
treatment in our samples was 2.9 years (Studies I and II) and 1.2 years (Study 
III). The short illness duration before treatment could be one reason why our 
results were more favorable compared to studies with adults. Moreover, it is 
promising that the results found in Study III indicate that the prognosis does 
not differ between responders to first-step CBT and those who needed 
extended treatment. These are important findings, in view of the lack of studies 
investigating the long-term outcomes of extended treatment for non-
responders to initial CBT. 
Psychosocial functioning  
Studies I and II found that the patients suffered from substantially impaired 
psychosocial functioning caused by OCD. Findings from baseline assessments 
with both the parent and child versions of COIS showed more severe 
impairment at baseline in comparison with findings from a previous study of 
childhood OCD (33). However, the participants’ psychosocial functioning 
significantly improved between the baseline assessment and the six-month and 
one-year follow-ups, as well as the two- and three-year evaluations. Study II 
showed that after three years, most participants had only little remaining 
impairments due to OCD symptoms. Even those individuals with moderate or 
severe OCD at baseline showed improved psychosocial functioning after three 
years.  
Depressive symptoms 
Few of the participants in Studies I and II had CDI scores indicating moderate 
to severe depression at baseline, and even fewer showed elevated levels on 
CDI scores after three years. This may indicate that for most of the sample the 
reported depressive symptoms at baseline were related to their OCD illness 
and did not constitute a primary affective disorder. 
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Methodological considerations 
Study participants representativeness 
This thesis comprises two different clinical groups of children and adolescents 
with OCD. Participants in Studies I and II were children and adolescents with 
OCD assessed and treated at a specialized clinic for outpatient care in 
Gothenburg, Sweden. The clinic has a primary position in the chain of care in 
that a majority of the sample was parent referred, or directly referred from 
local Child and Adolescent psychiatric (CAP) clinics without having received 
previous treatment. Compared with other studies where the unit was a tertiary 
national OCD clinic, it is likely that our sample is more representative of 
patients with OCD in ordinary CAP clinics. Comorbidity was common in the 
sample, as 78% percent of the participants had one or more comorbid 
diagnoses (48). This is reasonably in line with comorbidity rates found in other 
studies. (26, 47). Furthermore, few exclusion criteria were applied, and almost 
all of the potential study participants gave their consent. Hence, we conclude 
that these results are representative of patients with OCD at CAP clinics in 
general.  
In Study III, participants were recruited from Denmark, Norway, and Sweden, 
with two main study sites in the latter country, in Gothenburg and Stockholm. 
Furthermore, we included patients from various settings, both from outpatients 
in community-based clinics and from specialized OCD clinics. Including 
participants from various settings and keeping the exclusion criteria to a 
minimum suggests that our results are fairly representative of patients at CAP 
clinics as well.  
Attrition to follow-up assessments 
There was some attrition at the follow-up assessments in all three studies, 
however, more than three-fourths of the participants in Study I and nearly two-
thirds in Studies II and III participated at the follow-up assessments. For 
dichotomic outcomes, we used multiple imputation to handle missing data. 
Comparisons of descriptive data between participants with missing and non-
missing data at follow-up showed no significant differences between the 
groups. Thus, we assume that data were missing at random and therefore 
prerequisites for using multiple imputation are met. However, there is a risk 
that attrition skewed our results in ways that we cannot entirely estimate. For 
instance, drop-outs to follow-up may have responded less well to the 
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treatments than completers. Analyses in Study III of only the participants that 
completed their follow-up assessments gave even more positive outcomes than 
the ITT analysis showed. On the other hand, if many of those who dropped-
out at the follow-up assessments had responded well, the outcome from the 
ITT analysis may have underestimated the long-term treatment effects. 
However, due to the completer analysis in Study III, we do not believe this to 
be the case.  
Limitations and strengths 
The main limitation of the studies is the lack of a “no treatment” control 
groups, as we cannot say whether the outcome is due to our treatments or to 
spontaneous change, possibly reflecting developmental maturation. However, 
as previous long-term naturalistic outcome studies have indicated worse 
outcomes (71, 72, 126), we believe that it is unlikely that the long-term 
improvements can be attributed exclusively to spontaneous recovery. Since we 
have established and effective therapies for OCD today, it is not ethically to 
replace these effective methods with placebo that is known to be ineffective. 
Such a ”no treatment control” could have shown whether the treatments or 
spontaneous recovery was the more important factor. However, aside from the 
ethical problem, it would have been methodologically difficult to realize.  
Another limitation is that the follow-up assessments did not include any semi-
structured diagnostic instrument. However, the symptoms and severity of 
OCD were assessed by a standard clinical interview with the young people and 
their parents using the CY-BOCS, which was administered by trained 
independent assessors. Furthermore, not all the participants or their parents 
participated in all assessment points throughout the follow-up period. In 
Studies I and II, however, 74.3–78% of the young people participated in the 
six-month, one-year, and two-year follow-ups, and 61.5% completed their 
three-year assessment. In Study III, 63% and 62% completed the two- and 
three-year follow-up assessments, respectively. It should be noted, however, 
that the analyses of attrition showed no difference in severity of illness at 
baseline between those who participated versus those who did not participated 
in the follow-up assessments. Thus, the presence of selection bias seems 
unlikely. Furthermore, the attrition rate was less than attrition rates found in 
previous long-term studies (70-72).  
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Another limitation of Study II is the difference in sample size between 
responders and non-responders to the initial treatment, which may have biased 
the results of the comparative analyses between the groups somewhat.  
Moreover, all three studies were conducted in Nordic societies, which are 
socially stable with limited ethnic heterogeneity and limited socioeconomic 
differences. Therefore, our results may not generalize to populations with 
larger ethnic heterogeneity or socioeconomic divergence.  
Limitations aside, the three studies included in this thesis are the largest studies 
that have systematically evaluated the long-term outcomes of pediatric OCD 
within a prospective longitudinal design, and with repeated assessments during 
the three-year follow-up period. The main strengths of the studies are the 
repeated assessments during the follow-up period and well-characterized 
samples of outpatients. Further, the follow-up assessments were performed by 
independent raters at clinics. Symptom severity at baseline was similar to the 
level of symptom severity reported in other studies. These strengths, along 
with the fact that few exclusion criteria were applied in the studies, give a 
solidity to the results and make them generalizable to ordinary CAP units. 
Further strengths for Study III are that the sample consists of outpatients from 
various settings and that the manualized stepwise treatment is described 
robustly.  
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CONCLUSIONS 
• The majority of children and adolescents diagnosed with OCD have
a long-term positive outcome following evidence-based treatment for
pediatric OCD, which was individually adapted following expert
consensus guidelines (i.e., CBT and SSRI, when indicated).
• The long-term stability of treatment gains for children and
adolescents with OCD, participating in a stepwise manualized
treatment, is excellent. The immediate improvements after a first step
of manualized CBT (and, if needed, extended treatment with CBT or
a switch to pharmacotherapy with sertraline) are excellent, and
continued improvement ensues over time.
• Long-term improvements were also found with regard to
psychosocial functioning, and there was a reduction in depressive
symptoms. Further, the achieved improvements during treatment in
these areas were also maintained over time.
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FUTURE PERSPECTIVES 
Clinical implications 
Our findings suggest that the majority of patients respond well to treatment for 
pediatric OCD, and that treatment gains are maintained and further improved 
several years after treatment. Single treatment with CBT, preferably 
manualized, seems to be the most beneficial and safe treatment to offer young 
persons with OCD. Therapists need to be up-to-date regarding research on 
current treatment methods (e.g., further CBT advances), and on the 
development within assessments and diagnostic methods.  
Moreover, for some young persons, OCD-symptoms seem to wax and wane 
over time, and a small number of participants need additional treatment with 
either CBT or SSRI during the years following initial treatment. Thus, it is of 
importance to assess patients regularly for at least two years following 
effective treatment and, if needed, offer booster sessions and additional 
treatment. This is based on our clinical impression, but we consider that the 
outcome of our studies I and II sample and the three-year outcome of our 
NordLOTS sample support such a practice, as reported in this thesis. 
Conventionally, standardized CBT protocols for OCD range between 12 and 
16 weekly sessions. The optimal number of sessions, however, is unknown 
and may need to vary based upon individual patient characteristics. This study 
suggests that those who did not respond well to initial CBT could benefit from 
extended treatment protocols. The staff responsible for child psychiatric care 
should take into account the possibility of extending CBT treatment as an 
alternative to medication with SSRI, as the long-term effects of both treatment 
forms seem to be similar. It is of importance that the choice of SSRIs as 
treatment is based on person-centered care. The decision must be based on the 
patients’ and/or their parents’ preferences rather than, for example, a shortage 
of CBT resources or clinical routines. 
Restrictions of current CBT are not given by nature but are due to historical 
traditions. The rationale for the exposure-based CBT has historically been 
based on the emotion processing theory, in which habituation, is described as 
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the main process for successful exposure-based CBT. Recently, more attention 
has been focused on inhibitory learning as the explanatory model for 
successful exposures. This model focuses on the acquirement and 
strengthening of non-fear associations during non-reinforced exposures. The 
change of theoretical explanatory model may challenge therapists when 
performing exposure-based treatment. 
Future research 
Treatment of pediatric OCD shows favorable outcomes both post-treatment 
and at long-term follow-up. However, we do not know if the improvement 
persists into adulthood. We particularly lack knowledge about second-line 
treatment for pediatric OCD patients, in case of insufficient response to CBT.  
Thus, there is a need for considerably more long-term studies of childhood 
OCD to further understand the stability of treatment effects and consequences 
of the disorder throughout the child’s development and into adulthood. 
Hopefully, strategies for early diagnosis and step-wise treatments used for 
early onset psychosis and schizophrenia can serve as models and be developed 
for pediatric OCD as well. Such treatment strategies could be helpful in the 
development of person-centered care. 
Future CBT research should examine procedural changes (e.g., exposures 
based on the inhibition theory), and not allow historical approaches to set the 
limits on how to do CBT. The clinical usage of these strategies remains limited 
even if there is an interesting theoretical base for the emotional processing 
paradigm. Furthermore, there is a need for studies that assess these strategies 
in child clinical populations in order to evaluate the clinical outcomes and to 
verify whether these strategies improve on the extinction learning.  
Furthermore, it is important to try to identify predictors and mediators of long-
term outcome in order to be better able to individualize and personalize 
treatments more effectively, so that children are quickly allocated to the most 
likely beneficial interventions. 
The effect of treatment is usually evaluated based on measures of symptom 
level, and sometimes on other factors such as functional ability or quality of 
life. It is important to identify other factors that can affect the child’s well-
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being and ability to cooperate with treatment, such as lifestyle and family 
factors. Moreover, it is particularly important to examine lifestyle factors such 
as sleep, eating habits, and physical activity, both with regard to their impact 
on the child’s OCD symptoms and ability to benefit from the OCD treatment. 
This is of vital concern, as there is an increase in the number of children who 
sleep poorly, are physically inactive, or are malnourished (either eating too 
little or too much). Future studies need to assess such domains more closely.  
As demonstrated in this thesis, effective treatments for pediatric OCD have 
been developed. However, we need further collaborative care interventions, 
large multicenter studies, RCTs, and registry-based studies, to be able to 
improve present treatment interventions to help even more of those suffering 
from childhood OCD and to evaluate the short-term and long-term outcomes. 
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APPENDIX 
Appendix 1. 
An overview of the CBT treatment sessions in Study III. 
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Appendix 2. 
An overview of the pharmacotherapy sessions in Study III.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessments and dosing schedule in sertraline step 2 
Week Dose (mg) Range (mg) Assessments Actions 
    Check Adverse Events Scale (baseline) 
(AE), Somatic assessment (SA), Clinical 
Global Impression (CGI) 
0 25 × 3 days, then 50 25-50 CY-BOCS incl. CGI (use CY-BOCS at step 1 session 
13 if < 3 weeks, else reassessment in point 10c above), 
CGAS, blood pressure (BP), pulse, weight, length, 
side effects (AE) 
AE, SA, CGI, Clinical Global Impression - 
Improvement (CGI-I) 
2 75 50-75 CGI-I, CGI, BP, pulse, weight, length, side effects, 
treatment credibility 
AE, SA, CGI, CGI-I 
3-4 100 75-100 CGI-I, CGI, BP, pulse, weight, length, side effects AE, SA, CGI, CGI-I, dose correction based 
on response 
5-7 150 75-150 CGI-I, CGI, BP, pulse, weight, length, side effects, 
treatment credibility, KINDL (“independent rater”) 
AE, SA, CGI, CGI-I, dose correction 
on response 
8-12 200 75-200 CGI-I, CGI, BP, pulse, weight, length, side effects, 
treatment credibility 
AE, SA, CGI, CGI-I, dose correction based 
on response 
12-16 200 75-200 CY-BOCS incl. CGI/CGI-I, CGAS, Scared-R, MFQ, COIS, 
FAS, KINDL (“independent rater”), BP, pulse, weight, length, 
side effects, treatment credibility 
AE, SA, CGI, CGI-I, dose correction based 
on response 
 
 
